• Join today
  • Register for free newsletter
  • Sign In
  • Home
  • News
    • National Compliance Officer Day 2025
    • Accounting & Auditing
    • AI
    • AML
    • Anti-Bribery
    • Best Practices
    • Boards & Shareholders
    • Cryptocurrency and Digital Assets
    • Culture
    • ESG/Social Responsibility
    • Ethics & Culture
    • Europe
    • Financial Services
    • Internal Controls
    • Regulatory Enforcement
    • Regulatory Policy
    • Risk Management
    • Sanctions
    • Surveys & Benchmarking
    • Supply Chain
    • Third Party Risk
    • Whistleblowers
  • Benchmarking & Certification
    • HQP Program Assessment
    • LPEC
    • LPAIG
    • Access Course
  • Events
    • Third-Party Risk Management & Supply Chain Summit
    • CPE Accreditation Information
    • Webcasts
  • Research
    • Case Studies
    • Inside the Mind
    • e-Books
    • Survey Reports
    • Thought Leadership
    • Magazine Archive
  • Awards
  • App
  • Membership
  • Contact Us
  • Instagram
  • Linkedin
  • Email us
Skip to content
Compliance Week

Compliance Week

Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.

  • Join today
  • Register for free newsletter
  • Sign In
Sign In
  • Home
  • News
    • National Compliance Officer Day 2025
    • Accounting & Auditing
    • AI
    • AML
    • Anti-Bribery
    • Best Practices
    • Boards & Shareholders
    • Cryptocurrency and Digital Assets
    • Culture
    • ESG/Social Responsibility
    • Ethics & Culture
    • Europe
    • Financial Services
    • Internal Controls
    • Regulatory Enforcement
    • Regulatory Policy
    • Risk Management
    • Sanctions
    • Surveys & Benchmarking
    • Supply Chain
    • Third Party Risk
    • Whistleblowers
  • Benchmarking & Certification
    • HQP Program Assessment
    • LPEC
    • LPAIG
    • Access Course
  • Events
    • Third-Party Risk Management & Supply Chain Summit
    • CPE Accreditation Information
    • Webcasts
  • Research
    • Case Studies
    • Inside the Mind
    • e-Books
    • Survey Reports
    • Thought Leadership
    • Magazine Archive
  • Awards
  • App
  • Membership
  • Contact Us
Posted inFrom the Archive

AMAG Pharmaceuticals Elects New Board Members

by CW Staff February 8, 2012June 13, 2024

Share this:

  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

AMAG Pharmaceuticals has appointed Rajiv De Silva and Gino Santini to its board of directors.

Learn More
Already a member? Sign in to an existing account.
Tagged: CW Subscriber Only

Filter your search
By Type
By Topic
By Region
By Writer
By Date

Selecting a preset overrides the custom range.

Clear

Most Popular

From Audit Dread to Audit Ready: The Zero Trust WayJune 30, 2026
Compliance Week 2026 Excellence in Compliance AwardsJune 22, 2026
The Reverse Information Paradox: The role of compliance in AI governanceJuly 20, 2026
By creating a new AI and exams position, SEC may be ramping up Marketing Rule enforcementJuly 14, 2026
Practitioner lessons from Prudential Life of Japan’s scandalJuly 22, 2026

Where the field convenes. Privately.

A curated private community for credentialed ethics, risk, and compliance leaders across the ECI and Compliance Week network. Ask the questions you can’t post publicly and post anonymously when you need to. Share what you’re seeing on the ground.

  • Contact us
  • Advertise
  • My CW
  • CW Advisory Board
  • Email Preferences
  • CW Staff
  • Help
  • Media Inquiries
  • Media Toolkit
  • Editorial Submissions
  • Reprints
  • Search

Download the App

  • Terms and Conditions
  • Do Not Sell My Info
© 2026 Compliance Week, Inc. Powered by Newspack Privacy Policy
  • Instagram
  • Linkedin
  • Email us

Sign in or register

Or

Sign in by entering the code we sent to , or clicking the magic link in the email.

Forgot password
Continue Set a password (optional)

Verify your email

We'll send a verification code to %EMAIL%.

Gift this article

Loading Comments...